MONTE ROSA THERAPEUTICS INC's ticker is GLUE and the CUSIP is 61225M102. A total of 57 filers reported holding MONTE ROSA THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $209,965 | -34.9% | 43,834 | -6.8% | 0.00% | – |
| Q2 2023 | $322,306 | +47.7% | 47,052 | +67.9% | 0.00% | – |
| Q1 2023 | $218,284 | +2.1% | 28,021 | -0.2% | 0.00% | – |
| Q4 2022 | $213,734 | -4.6% | 28,086 | +2.6% | 0.00% | – |
| Q3 2022 | $224,000 | -16.7% | 27,382 | -1.6% | 0.00% | – |
| Q2 2022 | $269,000 | -14.3% | 27,835 | +24.2% | 0.00% | – |
| Q1 2022 | $314,000 | -7.4% | 22,411 | +35.0% | 0.00% | – |
| Q4 2021 | $339,000 | +143.9% | 16,603 | +165.6% | 0.00% | – |
| Q3 2021 | $139,000 | – | 6,252 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 1,472,331 | $7,052,465 | 2.91% |
| NEA Management Company, LLC | 7,692,298 | $36,846,107 | 2.85% |
| Octagon Capital Advisors LP | 812,895 | $3,893,767 | 0.60% |
| Alphabet Inc. | 1,464,015 | $7,012,631 | 0.45% |
| Avoro Capital Advisors LLC | 4,535,000 | $21,722,650 | 0.34% |
| Casdin Capital, LLC | 510,882 | $2,447,125 | 0.27% |
| Baker Brothers Advisors | 4,916,095 | $23,548,095 | 0.14% |
| Corton Capital Inc. | 14,460 | $69,263 | 0.04% |
| ExodusPoint Capital Management, LP | 619,248 | $2,966 | 0.03% |
| CORNERCAP INVESTMENT COUNSEL INC | 27,844 | $133,373 | 0.02% |